Symons Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Symons Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-164,065	Closed	-$9.7M	–	74
2015 Q2	$9.7M	Buy	164,065 +76,945	+88%	+$4.75M	2.41%	24
2015 Q1	$5.43M	Buy	87,120 +780	+0.9%	+$45.4K	1.24%	30
2014 Q4	$4.97M	Sell	86,340 -202,470	-70%	-$11.3M	1.18%	32
2014 Q3	$15.5M	Sell	288,810 -15,095	-5%	-$800K	3.28%	12
2014 Q2	$15.9M	Buy	303,905 +2,070	+0.7%	+$106K	3.55%	10
2014 Q1	$15.9M	Sell	301,835 -195,650	-39%	-$9.04M	3.65%	9
2013 Q4	$19.9M	Buy	497,485 +5,290	+1%	+$208K	4.6%	7
2013 Q3	$18.6M	Buy	+492,195	New	+$19.2M	5.04%	7

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Symons Capital Management's TEVA Position: Q3 2015 in Review

Symons Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 164,065 shares — an estimated $9.7M sold.

Symons Capital Management first reported a position in TEVA in Q3 2013 and held it in 8 quarters. The position peaked at $19.9M in Q4 2013. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Symons Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Symons Capital Management sold 164,065 Teva Pharmaceuticals shares in Q3 2015, an estimated $9.7M.
Symons Capital Management first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 8 quarters.
Symons Capital Management's Teva Pharmaceuticals position peaked at $19.9M in Q4 2013.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Symons Capital Management's 13F filing for Q3 2015, filed 30 Oct 2015.